Tobacco and other factors have a negative impact on quality of life in hepatitis C patients

Journal of Viral Hepatitis

Volumn 18, Issue 10, 2011, Pages 714-720

  Yamini, D ^a   Basseri, B ^a   Chee, G M ^a   Arakelyan, A ^a   Enayati, P ^a   Tran, T T ^a   Poordad, F ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

depression; difficulty sleeping; fatigue; hepatitis C virus; quality of life; sexual dysfunction; smoking

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC HEPATITIS; CIGARETTE SMOKING; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; ETHNIC GROUP; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HYPERLIPIDEMIA; INTRAVENOUS DRUG ABUSE; KIDNEY FAILURE; LIBIDO DISORDER; LIVER CIRRHOSIS; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SEXUAL DYSFUNCTION; TOBACCO; UNIVARIATE ANALYSIS; VIRUS HEPATITIS; VIRUS TRANSMISSION;

ADULT; ALCOHOL DRINKING; CROSS-SECTIONAL STUDIES; DEPRESSION; FATIGUE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SLEEP INITIATION AND MAINTENANCE DISORDERS; SMOKING;

EID: 80052850898     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01361.x     Document Type: Article

References (37)

1. Ware JE, Bungay K, Gandek B, et al. Assessment of the health-related quality of life (HQL) of patients with chronic hepatitis C (CHC). Gastroenterology 1994; 106: A393.
2. Carithers RL Jr, Sugano D, Bayliss MS,. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci 1996; 41 (Suppl. 12): 75S-80S.
3. Bayliss MS, Gandek B, Bungay KM, et al. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998; 7: 39-55. (Pubitemid 28113964)
4. Davis GL, Balart LA, Schiff ER, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 1994; 16: 334-343. (Pubitemid 24321668)
5. Foster GR, Goldin RD, Thomas HC,. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209-212.
6. Chong CA, Gulamhussein A, Heathcote EJ, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol 2003; 98: 630-638. (Pubitemid 36348537)
7. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35: 433-439. (Pubitemid 34106386)
8. Bonkovsky HL, Woolley JM,. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29: 264-270. (Pubitemid 29024012)
9. Basseri B, Yamini D, Enayati P, et al. Demographics, co-morbidities, social behaviors, and laboratory data: which factors predict fibrosis in the natural history of hepatitis C?. Gastroenterology 2009; 136 (5: Suppl. 1): M1772.
10. Dieperink E, Willenbring M, Ho SB,. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000; 157: 867-876. (Pubitemid 30412335)
11. Cotler SJ, Wartelle CF, Larson AM, et al. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat 2000; 7: 211-217. (Pubitemid 30337617)
12. Lee DH, Jamal H, Regenstein FG, et al. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997; 42: 186-191. (Pubitemid 27059942)
13. Dwight MM, Kowdley KV, Russo JE, et al. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 2000; 49: 311-317. (Pubitemid 32123807)
14. Hoofnagle JH,. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26 (3 Suppl. 1): 15S-20S. (Pubitemid 27388066)
15. Rodger AJ, Jolley D, Thompson SC, et al. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 1299-1301. (Pubitemid 29510870)
16. Rabkin JG, Johnson J, Lin SH, et al. Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years. AIDS 1997; 11: 507-515. (Pubitemid 27113013)
17. Bouffard P, Hayashi PH, Acevedo R, et al. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992; 166: 1276-1280.
18. Hunt CM, Dominitz JA, Bute BP, et al. Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci 1997; 42: 2482-2486. (Pubitemid 28103784)
19. Lang CA, Conrad S, Garrett L, et al. Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. J Pain Symptom Manage 2006; 31: 335-344.
20. Kramer L, Bauer E, Funk G, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37: 349-354. (Pubitemid 34969951)
21. Danoff A, Khan O, Wan DW, et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol 2006; 101: 1235-1243. (Pubitemid 43829989)
22. Bonkovsky HL, Snow KK, Malet PF, et al. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol 2007; 46: 420-431. (Pubitemid 46201722)
23. Soykan A, Boztaş H, Idilman R, et al. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res 2005; 17: 175-179. (Pubitemid 40434593)
24. Marumo K, Nakashima J, Murai M,. Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol 2001; 8: 53-59. (Pubitemid 32245343)
25. Ferri C, Bertozzi MA, Zignego AL,. Erectile dysfunction and hepatitis C virus infection. JAMA 2002; 288: 698-699. (Pubitemid 34848221)
26. Kendall JC, Sherman MF, Bigelow GE,. Psychiatric symptoms in polysubstance abusers: relationship to race, sex, and age. Addict Behav 1995; 20: 685-690.
27. Lipsitz JD, Williams JB, Rabkin JG, et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry 1994; 15: 1662-1668. (Pubitemid 24337601)
28. Balfour L, Cooper C, Kowal J, et al. Depression and cigarette smoking independently relate to reduced health-related quality of life among Canadians living with hepatitis C. Can J Gastroenterol 2006; 20: 81-86.
29. Houston TK, Person SD, Pletcher MJ, et al. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 2006; 332: 1064-1069.
30. Leandro G, Mangia A, Hui J, et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006; 130: 1636-1642.
31. De Luca L, De Angeles C, Fagoonee S, et al. Is smoking a prognostic factor in patients with chronic hepatitis C? Minerva Gastroenterol Dietol 2009; 55: 139-143.
32. Dev A, Patel K, Conrad A, et al. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2006; 4: 797-801. (Pubitemid 43825810)
33. Pessione F, Ramond MJ, Njapoum C, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001; 34: 121-125. (Pubitemid 32591491)
34. Hézode C, Lonjon I, Roudot-Thoraval F, et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003; 52: 126-129. (Pubitemid 36020778)
35. Wang CS, Wang ST, Chang TT, et al. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-815.
36. Sopori ML, Kozak W,. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998; 83: 148-156. (Pubitemid 28280961)
37. Meliska CJ, Stunkard ME, Gilbert DG, et al. Immune function in cigarette smokers who quit smoking for 31 days. J Allergy Clin Immunol 1995; 95: 901-910.